Laurent Castera

Professor of Hepatology, University of Paris-VII and Visiting Professor of Medicine, UCL
This year the Global NASH Congress is being held virtually. The platform we have chosen is designed to facilitate collaboration between the multiple stakeholders who attend this meeting. This will enable you to seamlessly network with key opinion leaders, investigators & researchers from across, academia, pharma, providers and regulators.
Watch this video to discover more
In 2021 the conference will once again explore the advances being made in research and development in pathogenesis, diagnosis and treatment of the disease. Our multi-disciplinary speaker panel will give you their insights on these developments as well as reporting on clinical trials.
“I really enjoyed the scientific content of the conference with news from providers and Pharma organisations.” Delegate Pharma Company
“There was a good variety of speakers & content with ample networking opportunities” NHS Delegate
“A very good spread of content with topics that were applicable to a wide audience.”Academic delegate
“Well organised, varied content covering the main aspects of NASH and drug development.” Speaker
“I appreciated the broad spectrum of areas within NASH from clinical trials and biomarker to scientific new projects. The conference provided a nice overview of the field as of today.” Sponsor
This programme creates a collaborative environment in which you can create enduring relationships across the full range of disciplines engaged in NASH research & drug discovery and development.
Clinical Development & Trial Design Optimization
Exploring factors for advances in treatment – such as:
Professor of Pathology, University of Paris, Visiting Professor at Translational and Clinical Research Institute, Faculty of Newcastle, UK and Director of Liverpat, Paris, France
Chief Medical Officer, Galectin Therapeutics
Full Professor of Medicine, Faculty of Medicine, University of Lisbon
Senior Vice President, Chief Medical Officer, NGM Biopharmaceuticals, USA
Professor of Medicine, University of Sydney, Australia
Professor of Epigenetics, Fibrosis Research Group, Newcastle University, UK Laurent Castera, Professor of Hepatology, University of Paris-VII (Department of Hepatology, Hôpital Beaujon, Clichy, France
Director, Clinical and Translational Imaging, Novartis
SVP Clinical Pharmacology and Analytic, Hepion Pharmaceuticals Inc.
Professor, Senior Consultant, Principal Investigator, University of Gothenburg, Sweden
Chief Scientist, Research and Early Development, CVRM, BioPharmaceuticals R&D, AstraZeneca
Professor in Gastroenterology & Hepatology, School of Medicine, Trinity College Dublin
Professor in Pathology, Chair, Pathology Dept, Beaujon Hospital, Clichy, Inserm
Principal Scientist, Glympse Bio
Medical Officer, Food and Drug Administration
Translational Scientist, Owlstone Medical Ltd
Chairman, Division of Gastroenterology and Hepatology, Antwerp University Hospital, Belgium
Chief Medical Officer, 89bio
Professor of Pharmacogenetics, Newcastle University, UK
Chief Medical Officer and President, Research & Development, Madrigal Pharmaceuticals, USA
Chief Medical Officer, Metacrine
Clinical Assessor, Licensing Division 2, Federal Institute for Drugs and Medical Devices (BfArM)
Executive Vice President, Global Head of Diagnostics, Genfit
Professor of Internal Medicine and Hepatology, Head Division of Hepatology, University Hospital Würzburg, Germany
Assistant Professor, Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Portugal
Associate Professor, Head of School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa & Department of Gastroenterology and Hepatology, The Tel- Aviv Medical Center, Israel
Senior Director, Biomarker Sciences, Gilead
Professor of Medicine, Virginia Commonwealth University, Acting Chief of Gastroenterology, Central Virginia VA Health Care System (CVHCS), Chief of Hepatology & Liver Transplantation, CVHCS, Director of GI Research, McGuire Research Institute
Senior Research Scientist, Gilead
Independent Consultant Gastroenterologist and Hepatologist, Locarno, Ticino, Switzerland
Professor, Department of Gastroenterology and Hepatology, University of Gent
Vice President, Clinical Development, Abbvie
Chief Scientific Officer, Galmed Pharmaceutical Ltd
Chairman and Professor of Medicine, Department of Hepatology & Gastroenterology, Charité University Medicine Berlin
Senior Director, Regulatory Affairs, Nordic Bioscience
Executive Director, Internal Medicine Research Unit, Pfizer Inc
CEO, InfiCure Bio
Professor of Pathology, University of Paris, Visiting Professor at Translational and Clinical Research Institute, Faculty of Newcastle, UK and Director of Liverpat, Paris, France
Chief Medical Officer, Galectin Therapeutics
Full Professor of Medicine, Faculty of Medicine, University of Lisbon
Senior Vice President, Chief Medical Officer, NGM Biopharmaceuticals, USA
Professor of Medicine, University of Sydney, Australia
Professor of Epigenetics, Fibrosis Research Group, Newcastle University, UK Laurent Castera, Professor of Hepatology, University of Paris-VII (Department of Hepatology, Hôpital Beaujon, Clichy, France
Director, Clinical and Translational Imaging, Novartis
SVP Clinical Pharmacology and Analytic, Hepion Pharmaceuticals Inc.
Professor, Senior Consultant, Principal Investigator, University of Gothenburg, Sweden
Chief Scientist, Research and Early Development, CVRM, BioPharmaceuticals R&D, AstraZeneca
Professor in Gastroenterology & Hepatology, School of Medicine, Trinity College Dublin
Professor in Pathology, Chair, Pathology Dept, Beaujon Hospital, Clichy, Inserm
Principal Scientist, Glympse Bio
Medical Officer, Food and Drug Administration
Translational Scientist, Owlstone Medical Ltd
Chairman, Division of Gastroenterology and Hepatology, Antwerp University Hospital, Belgium
Chief Medical Officer, 89bio
Professor of Pharmacogenetics, Newcastle University, UK
Chief Medical Officer and President, Research & Development, Madrigal Pharmaceuticals, USA
Chief Medical Officer, Metacrine
Clinical Assessor, Licensing Division 2, Federal Institute for Drugs and Medical Devices (BfArM)
Executive Vice President, Global Head of Diagnostics, Genfit
Professor of Internal Medicine and Hepatology, Head Division of Hepatology, University Hospital Würzburg, Germany
Assistant Professor, Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Portugal
Associate Professor, Head of School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa & Department of Gastroenterology and Hepatology, The Tel- Aviv Medical Center, Israel
Senior Director, Biomarker Sciences, Gilead
Professor of Medicine, Virginia Commonwealth University, Acting Chief of Gastroenterology, Central Virginia VA Health Care System (CVHCS), Chief of Hepatology & Liver Transplantation, CVHCS, Director of GI Research, McGuire Research Institute
Senior Research Scientist, Gilead
Independent Consultant Gastroenterologist and Hepatologist, Locarno, Ticino, Switzerland
Professor, Department of Gastroenterology and Hepatology, University of Gent
Vice President, Clinical Development, Abbvie
Chief Scientific Officer, Galmed Pharmaceutical Ltd
Chairman and Professor of Medicine, Department of Hepatology & Gastroenterology, Charité University Medicine Berlin
Senior Director, Regulatory Affairs, Nordic Bioscience
Executive Director, Internal Medicine Research Unit, Pfizer Inc
CEO, InfiCure Bio
Track hop and access all presentations
Give a poster presentation
Join networking discussion rooms
Access the virtual exhibition room
Priority networking with other attendees
Create post-event connections
Conference workbook
Presentations will be available on-demand shortly after the meeting
Register for three, five or ten passes for a substantial discount
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
You can book securely inside the virtual event platform to get your login details instantly.
To pay by invoice, please contact [email protected]
Prices:
Standard rate ** | €299 |
Solution Provider rate + | €799 |
Group booking: 3 Passes ** | €750 |
Group booking: 5 Passes ** | €1100 |
Group booking: 10 Passes ** | €1900 |
* Book before 28th February 2021 and save 10% on the Standard fee. (Offer not available to solution providers.)
** For pharma, biotech or academic institutions
+ For organisations offering services or technology to pharma or academic research institutions. Access all networking features.
Organisations offering services and/or business & technology solutions and business consultants please contact Tony Couch or Gavin Hambrook to discuss participation at this meeting.
Accelerated Enrollment Solutions (AES) is the new standard in clinical trial productivity. Our innovative and integrated site and patient services secure the success of clinical trials by providing enrollment, timing, and budget certainty. AES offers sponsors and contract research organizations best-in-class site conduct and patient access solutions, which include engaging, recruiting and retaining patients in clinical studies via a global network of dedicated research sites.
×Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by breath-based diagnostics, through the development and application of Breath Biopsy®. Breath Biopsy operates by detecting volatile organic compounds (VOCs) produced as the end product of metabolic processes within the body or as a result of chemicals from external sources such as diet or medication, changes in which can be characteristic of specific disease or indicate environmental exposure.
https://www.owlstonemedical.com
×
InfiCure Bio has developed a unique preclinical model, the NIF mouse, which spontaneously develops chronic inflammation and fibrosis of the liver.
We offer expert led, tailored, high-quality drug validation services for R&D companies and CRO’s.
Our unique NIF mouse offers the possibility to distinguish between metabolic and immunological actions of tested substances.
The pathological progress is similar to many human conditions and the spontaneous development makes it possible for us to shorten test protocols.
Aiforia is a versatile cloud-based platform that increases the speed and accuracy of analyzing medical images across a variety of fields by providing healthcare professionals direct access to deep learning AI. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries, clinical support and highly accurate and consistent data.
×SomaLogic seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals to optimize their health and wellness throughout their lives. We work with a global network of partners and users to derive and deliver this information through the SomaScan® Platform, SomaLogic’s proprietary protein measurement technology, across many different health-related markets and providers. To learn more about us and how you can work with us to transform your own healthcare efforts, visit http://somalogic.com/somascan-access.
×At Thermo Fisher Scientific, our mission is to enable our customers to make the world healthier, cleaner and safer. Gibco media, supplements, cells, and cell culture reagents are designed to deliver reproducibility and performance for results you can count on every day. Regardless of whether you are performing cell culture in research labs, need a special or defined formulation, or are growing cell lines, primary, or stem cells, Gibco products offer a reliable solution.
https://www.thermofisher.com/us/en/home/brands/gibco.html
×As the Research Division of BioTelemetry, Inc., BioTel Research offers medical imaging and cardiac safety testing services for clinical trials – supporting the advancement of biopharmaceutical development worldwide. With an ideal combination of global experience and personal access, BioTel Research combines the agility and accessibility of a small lab with the reach and experience of a large clinical trials services provider.
www.gobio.com/clinical-research/
×Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.
https://www.cerbaresearch.com/
×Established in 2007, Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. Our digital health solution, Simoa®, has the potential to change today’s approach to healthcare by giving researchers the ability to closely examine the continuum from health to disease. Simoa® is designed to enable earlier disease detection, better prognoses and enhanced treatment methods. Current research applications include oncology, neurology, immunology, infectious disease and cardiology.
×
TNO Healthy Living is the innovation partner that in joint cooperation with the public and private sector enables technological and social innovations that support citizens and professionals to make the right (preventive) choices that promote a healthy, vital and productive population. In this way we act as the flywheel of innovation that supports improved affordability and quality of health, lower healthcare costs and sustainable economic growth.
×In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ technology for liver stiffness assessment, and CAP™ technology for steatosis quantification.
FibroScan® device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,000 medical publications and 40 guidelines recommendations.
We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.
As patient education is a major issue, we have created the “myliverexam” website that provides information about the role of the liver and why it is vital to the global health.
×As innovators in the rapidly-evolving medical education landscape, Liberum IME, (part of OPEN Health) continually finds creative solutions to deliver globally-relevant science in the context of local practice. Our evidence-based education is tailored to the specific needs of healthcare professionals, inspiring self-reflection to drive measurable practice change and improve patient care. We are dedicated to sharing best practice through international collaboration, allowing healthcare professionals worldwide to put science into practice.
×PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly to provide quality results for clients. We offer specialized expertise across all phases and therapeutic areas and a broad spectrum of full-service and strategic solutions.
With 16,000+ employees covering 90+ countries, we give you the global presence you expect, combined with an in-depth knowledge of local regulations, standards of care, and cultural customs.
At PRA, we love what do, because we are making a difference in the lives of patients and their family members worldwide. We have contributed to the development of numerous drugs now available.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and/or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas. The booth allows you to provide a pre-recorded video or deliver a live video session to your visitors and capture emails when people register their interest. Live chat with your visitors in discussion groups or 1:1.
Options include:
For further details please contact
Tony Couch or Gavin Hambrook
Telephone +44 (0) 1865 849841
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees with your full abstract in and can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this Congress.
In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).
Submit your application by April 16, 2021
Hep magazine and HepMag.com are the go-to sources for educational and social support for people living with liver diseases like hepatitis C, hepatitis B, hepatitis A and NASH. Launched in 2010, the website is devoted to combating the stigma and isolation surrounding liver diseases and offers news, in-depth reporting, educational tools, care resources, and peer-to-peer networking.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, keeping a tab on the updated and latest updates and trends concerning the field.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the event’s website and more…
If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in Clocate.com.